The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and FlutterFocus on Ibutilide

被引:0
|
作者
Owen A. Obel
A. John Camm
机构
[1] St George’s Hospital Medical School,Department of Cardiological Sciences
来源
Drugs & Aging | 1998年 / 12卷
关键词
Atrial Fibrillation; Adis International Limited; Amiodarone; Sinus Rhythm; Flecainide;
D O I
暂无
中图分类号
学科分类号
摘要
Atrial fibrillation (AF) is the most common sustained arrhythmia, particularly in the elderly population. It is well recognised that AF is a major cause of stroke, even in the absence of underlying heart disease. Although AF and atrial flutter share many causes and may be seen in the same patient, there are differences between these arrhythmias: atrial flutter is less common, and the risk of stroke associated with it is less than that with AF. In addition to stroke, both AF and atrial flutter may cause cardiomyopathy, which may be fully reversible with effective treatment of the arrhythmia. Both AF and atrial flutter can result in severe symptoms and may precipitate heart failure, ischaemia and syncope. Recent research indicates that AF is a self-perpetuating arrhythmia, and that the longer it is left untreated the less likely it is that effective cardioversion will be possible.
引用
收藏
页码:461 / 476
页数:15
相关论文
共 50 条
  • [21] Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide
    Dasgupta, Soham
    Dave, Ishaan
    Whitehill, Robert
    Fischbach, Peter
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2020, 43 (03): : 322 - 326
  • [22] Ibutilide-induced cardioversion of atrial fibrillation during pregnancy
    Kockova, Radka
    Kocka, Viktor
    Kiernan, Thomas
    Fahy, Gerard J.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2007, 18 (05) : 545 - 547
  • [23] Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods
    Naegeli, B
    Straumann, E
    Bertel, O
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (02) : 283 - 287
  • [24] Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed
    Hennersdorf, MG
    Perings, SM
    Zühlke, C
    Heidland, UE
    Perings, C
    Heintzen, MP
    Strauer, BE
    INTENSIVE CARE MEDICINE, 2002, 28 (07) : 925 - 929
  • [25] Safety and Effectiveness of Antidysrhythmic Drugs for Pharmacologic Cardioversion of Recent-Onset Atrial Fibrillation: a Systematic Review and Bayesian Network Meta-analysis
    Desouza, Ian S.
    Shrestha, Pragati
    Allen, Robert
    Koos, Jessica
    Thode Jr, Henry
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [26] Pharmacologic cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis
    deSouza, Ian S.
    Tadrous, Mina
    Sexton, Theresa
    Benabbas, Roshanak
    Carmelli, Guy
    Sinert, Richard
    EUROPACE, 2020, 22 (06): : 854 - 869
  • [27] Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation
    Conde, Diego
    Lalor, Nicolas
    Rodriguez, Leandro
    Elissamburu, Pablo
    Trivi, Marcelo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4431 - 4432
  • [28] Is delayed cardioversion the better approach in recent-onset atrial fibrillation? No
    Alessandro Capucci
    Paolo Compagnucci
    Internal and Emergency Medicine, 2020, 15 : 5 - 7
  • [29] Cardioversion of recent-onset atrial fibrillation using intravenous antiarrhythmics: A European perspective
    Levy, Samuel
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (12) : 3259 - 3269
  • [30] Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone
    Fragakis, N
    Papadopoulos, N
    Papanastasiou, S
    Kozirakis, M
    Maligkos, G
    Tsaritsaniotis, E
    Katsaris, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (09): : 954 - 961